Global Anti-Infective Vaccines Market Research Report 2023

Global Anti-Infective Vaccines Market Research Report 2023

Table of Contents
1 Anti-Infective Vaccines Market Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Anti-Infective Vaccines Segment by Type
1.2.1 Global Anti-Infective Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Inactivated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Live/attenuated Vaccines
1.3 Anti-Infective Vaccines Segment by Application
1.3.1 Global Anti-Infective Vaccines Market Value by Application: (2023-2029)
1.3.2 Bacterial Diseases
1.3.3 Viral Diseases
1.4 Global Anti-Infective Vaccines Market Size Estimates and Forecasts
1.4.1 Global Anti-Infective Vaccines Revenue 2018-2029
1.4.2 Global Anti-Infective Vaccines Sales 2018-2029
1.4.3 Global Anti-Infective Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-Infective Vaccines Market Competition by Manufacturers
2.1 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-Infective Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Infective Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-Infective Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Infective Vaccines, Product Type & Application
2.7 Anti-Infective Vaccines Market Competitive Situation and Trends
2.7.1 Anti-Infective Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Infective Vaccines Players Market Share by Revenue
2.7.3 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infective Vaccines Retrospective Market Scenario by Region
3.1 Global Anti-Infective Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-Infective Vaccines Global Anti-Infective Vaccines Sales by Region: 2018-2029
3.2.1 Global Anti-Infective Vaccines Sales by Region: 2018-2023
3.2.2 Global Anti-Infective Vaccines Sales by Region: 2024-2029
3.3 Global Anti-Infective Vaccines Global Anti-Infective Vaccines Revenue by Region: 2018-2029
3.3.1 Global Anti-Infective Vaccines Revenue by Region: 2018-2023
3.3.2 Global Anti-Infective Vaccines Revenue by Region: 2024-2029
3.4 North America Anti-Infective Vaccines Market Facts & Figures by Country
3.4.1 North America Anti-Infective Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-Infective Vaccines Sales by Country (2018-2029)
3.4.3 North America Anti-Infective Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Infective Vaccines Market Facts & Figures by Country
3.5.1 Europe Anti-Infective Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-Infective Vaccines Sales by Country (2018-2029)
3.5.3 Europe Anti-Infective Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Infective Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-Infective Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-Infective Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Infective Vaccines Market Facts & Figures by Country
3.7.1 Latin America Anti-Infective Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-Infective Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Anti-Infective Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Infective Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-Infective Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-Infective Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Infective Vaccines Sales by Type (2018-2029)
4.1.1 Global Anti-Infective Vaccines Sales by Type (2018-2023)
4.1.2 Global Anti-Infective Vaccines Sales by Type (2024-2029)
4.1.3 Global Anti-Infective Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Anti-Infective Vaccines Revenue by Type (2018-2029)
4.2.1 Global Anti-Infective Vaccines Revenue by Type (2018-2023)
4.2.2 Global Anti-Infective Vaccines Revenue by Type (2024-2029)
4.2.3 Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Anti-Infective Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-Infective Vaccines Sales by Application (2018-2029)
5.1.1 Global Anti-Infective Vaccines Sales by Application (2018-2023)
5.1.2 Global Anti-Infective Vaccines Sales by Application (2024-2029)
5.1.3 Global Anti-Infective Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Anti-Infective Vaccines Revenue by Application (2018-2029)
5.2.1 Global Anti-Infective Vaccines Revenue by Application (2018-2023)
5.2.2 Global Anti-Infective Vaccines Revenue by Application (2024-2029)
5.2.3 Global Anti-Infective Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Anti-Infective Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Emergent BioDefense Operations Lansing Inc.
6.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
6.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
6.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio
6.1.5 Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Pasteur Anti-Infective Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck & Co.
6.3.1 Merck & Co. Corporation Information
6.3.2 Merck & Co. Description and Business Overview
6.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck & Co. Anti-Infective Vaccines Product Portfolio
6.3.5 Merck & Co. Recent Developments/Updates
6.4 MedImmune LLC
6.4.1 MedImmune LLC Corporation Information
6.4.2 MedImmune LLC Description and Business Overview
6.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MedImmune LLC Anti-Infective Vaccines Product Portfolio
6.4.5 MedImmune LLC Recent Developments/Updates
6.5 Novartis Vaccines
6.5.1 Novartis Vaccines Corporation Information
6.5.2 Novartis Vaccines Description and Business Overview
6.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novartis Vaccines Anti-Infective Vaccines Product Portfolio
6.5.5 Novartis Vaccines Recent Developments/Updates
6.6 Diagnostics Ltd.
6.6.1 Diagnostics Ltd. Corporation Information
6.6.2 Diagnostics Ltd. Description and Business Overview
6.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio
6.6.5 Diagnostics Ltd. Recent Developments/Updates
6.7 Intercell Biomedical
6.6.1 Intercell Biomedical Corporation Information
6.6.2 Intercell Biomedical Description and Business Overview
6.6.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intercell Biomedical Anti-Infective Vaccines Product Portfolio
6.7.5 Intercell Biomedical Recent Developments/Updates
6.8 MassBiologics
6.8.1 MassBiologics Corporation Information
6.8.2 MassBiologics Description and Business Overview
6.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MassBiologics Anti-Infective Vaccines Product Portfolio
6.8.5 MassBiologics Recent Developments/Updates
6.9 Barr Labs, Inc.
6.9.1 Barr Labs, Inc. Corporation Information
6.9.2 Barr Labs, Inc. Description and Business Overview
6.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio
6.9.5 Barr Labs, Inc. Recent Developments/Updates
6.10 Organon Teknika Co.
6.10.1 Organon Teknika Co. Corporation Information
6.10.2 Organon Teknika Co. Description and Business Overview
6.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Organon Teknika Co. Anti-Infective Vaccines Product Portfolio
6.10.5 Organon Teknika Co. Recent Developments/Updates
6.11 GlaxoSmithKline Biologicals
6.11.1 GlaxoSmithKline Biologicals Corporation Information
6.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Description and Business Overview
6.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio
6.11.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.12 CSL Ltd.
6.12.1 CSL Ltd. Corporation Information
6.12.2 CSL Ltd. Anti-Infective Vaccines Description and Business Overview
6.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CSL Ltd. Anti-Infective Vaccines Product Portfolio
6.12.5 CSL Ltd. Recent Developments/Updates
6.13 ID Biomedical Co.
6.13.1 ID Biomedical Co. Corporation Information
6.13.2 ID Biomedical Co. Anti-Infective Vaccines Description and Business Overview
6.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ID Biomedical Co. Anti-Infective Vaccines Product Portfolio
6.13.5 ID Biomedical Co. Recent Developments/Updates
6.14 Protein Sciences Co.
6.14.1 Protein Sciences Co. Corporation Information
6.14.2 Protein Sciences Co. Anti-Infective Vaccines Description and Business Overview
6.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Protein Sciences Co. Anti-Infective Vaccines Product Portfolio
6.14.5 Protein Sciences Co. Recent Developments/Updates
6.15 Wyeth Pharmaceuticals, Inc.
6.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
6.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Description and Business Overview
6.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio
6.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
6.16 Berna Biotech
6.16.1 Berna Biotech Corporation Information
6.16.2 Berna Biotech Anti-Infective Vaccines Description and Business Overview
6.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Berna Biotech Anti-Infective Vaccines Product Portfolio
6.16.5 Berna Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Infective Vaccines Industry Chain Analysis
7.2 Anti-Infective Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Infective Vaccines Production Mode & Process
7.4 Anti-Infective Vaccines Sales and Marketing
7.4.1 Anti-Infective Vaccines Sales Channels
7.4.2 Anti-Infective Vaccines Distributors
7.5 Anti-Infective Vaccines Customers
8 Anti-Infective Vaccines Market Dynamics
8.1 Anti-Infective Vaccines Industry Trends
8.2 Anti-Infective Vaccines Market Drivers
8.3 Anti-Infective Vaccines Market Challenges
8.4 Anti-Infective Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Anti-Infective Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Anti-Infective Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Anti-Infective Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-Infective Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-Infective Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-Infective Vaccines Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-Infective Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Anti-Infective Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Infective Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Infective Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Infective Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti-Infective Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-Infective Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Anti-Infective Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Anti-Infective Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Anti-Infective Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-Infective Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-Infective Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti-Infective Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-Infective Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Anti-Infective Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-Infective Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-Infective Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Anti-Infective Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-Infective Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti-Infective Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti-Infective Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-Infective Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Anti-Infective Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-Infective Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-Infective Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Anti-Infective Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-Infective Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-Infective Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti-Infective Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-Infective Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti-Infective Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-Infective Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Anti-Infective Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Anti-Infective Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Anti-Infective Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-Infective Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti-Infective Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-Infective Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2018-2023)
Table 59. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2024-2029)
Table 60. Global Anti-Infective Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-Infective Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Anti-Infective Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Anti-Infective Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Anti-Infective Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-Infective Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Anti-Infective Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-Infective Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Anti-Infective Vaccines Price (US$/Unit) by Application (2018-2023)
Table 69. Global Anti-Infective Vaccines Price (US$/Unit) by Application (2024-2029)
Table 70. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 71. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 72. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 74. Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sanofi Pasteur Anti-Infective Vaccines Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Merck & Co. Corporation Information
Table 81. Merck & Co. Description and Business Overview
Table 82. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck & Co. Anti-Infective Vaccines Product
Table 84. Merck & Co. Recent Developments/Updates
Table 85. MedImmune LLC Corporation Information
Table 86. MedImmune LLC Description and Business Overview
Table 87. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. MedImmune LLC Anti-Infective Vaccines Product
Table 89. MedImmune LLC Recent Developments/Updates
Table 90. Novartis Vaccines Corporation Information
Table 91. Novartis Vaccines Description and Business Overview
Table 92. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Novartis Vaccines Anti-Infective Vaccines Product
Table 94. Novartis Vaccines Recent Developments/Updates
Table 95. Diagnostics Ltd. Corporation Information
Table 96. Diagnostics Ltd. Description and Business Overview
Table 97. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Diagnostics Ltd. Anti-Infective Vaccines Product
Table 99. Diagnostics Ltd. Recent Developments/Updates
Table 100. Intercell Biomedical Corporation Information
Table 101. Intercell Biomedical Description and Business Overview
Table 102. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Intercell Biomedical Anti-Infective Vaccines Product
Table 104. Intercell Biomedical Recent Developments/Updates
Table 105. MassBiologics Corporation Information
Table 106. MassBiologics Description and Business Overview
Table 107. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. MassBiologics Anti-Infective Vaccines Product
Table 109. MassBiologics Recent Developments/Updates
Table 110. Barr Labs, Inc. Corporation Information
Table 111. Barr Labs, Inc. Description and Business Overview
Table 112. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Barr Labs, Inc. Anti-Infective Vaccines Product
Table 114. Barr Labs, Inc. Recent Developments/Updates
Table 115. Organon Teknika Co. Corporation Information
Table 116. Organon Teknika Co. Description and Business Overview
Table 117. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Organon Teknika Co. Anti-Infective Vaccines Product
Table 119. Organon Teknika Co. Recent Developments/Updates
Table 120. GlaxoSmithKline Biologicals Corporation Information
Table 121. GlaxoSmithKline Biologicals Description and Business Overview
Table 122. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product
Table 124. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 125. CSL Ltd. Corporation Information
Table 126. CSL Ltd. Description and Business Overview
Table 127. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. CSL Ltd. Anti-Infective Vaccines Product
Table 129. CSL Ltd. Recent Developments/Updates
Table 130. ID Biomedical Co. Corporation Information
Table 131. ID Biomedical Co. Description and Business Overview
Table 132. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. ID Biomedical Co. Anti-Infective Vaccines Product
Table 134. ID Biomedical Co. Recent Developments/Updates
Table 135. Protein Sciences Co. Corporation Information
Table 136. Protein Sciences Co. Description and Business Overview
Table 137. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Protein Sciences Co. Anti-Infective Vaccines Product
Table 139. Protein Sciences Co. Recent Developments/Updates
Table 140. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 141. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 142. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product
Table 144. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
Table 145. Berna Biotech Corporation Information
Table 146. Berna Biotech Description and Business Overview
Table 147. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Berna Biotech Anti-Infective Vaccines Product
Table 149. Berna Biotech Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Anti-Infective Vaccines Distributors List
Table 153. Anti-Infective Vaccines Customers List
Table 154. Anti-Infective Vaccines Market Trends
Table 155. Anti-Infective Vaccines Market Drivers
Table 156. Anti-Infective Vaccines Market Challenges
Table 157. Anti-Infective Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Infective Vaccines
Figure 2. Global Anti-Infective Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Anti-Infective Vaccines Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Live/attenuated Vaccines Product Picture
Figure 7. Global Anti-Infective Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Anti-Infective Vaccines Market Share by Application in 2022 & 2029
Figure 9. Bacterial Diseases
Figure 10. Viral Diseases
Figure 11. Global Anti-Infective Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Anti-Infective Vaccines Market Size (2018-2029) & (US$ Million)
Figure 13. Global Anti-Infective Vaccines Sales (2018-2029) & (K Units)
Figure 14. Global Anti-Infective Vaccines Average Price (US$/Unit) & (2018-2029)
Figure 15. Anti-Infective Vaccines Report Years Considered
Figure 16. Anti-Infective Vaccines Sales Share by Manufacturers in 2022
Figure 17. Global Anti-Infective Vaccines Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Anti-Infective Vaccines Players: Market Share by Revenue in 2022
Figure 19. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Anti-Infective Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Anti-Infective Vaccines Sales Market Share by Country (2018-2029)
Figure 22. North America Anti-Infective Vaccines Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Anti-Infective Vaccines Sales Market Share by Country (2018-2029)
Figure 26. Europe Anti-Infective Vaccines Revenue Market Share by Country (2018-2029)
Figure 27. Germany Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2018-2029)
Figure 34. China Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Anti-Infective Vaccines Sales Market Share by Country (2018-2029)
Figure 45. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Anti-Infective Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-Infective Vaccines by Type (2018-2029)
Figure 55. Global Revenue Market Share of Anti-Infective Vaccines by Type (2018-2029)
Figure 56. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Anti-Infective Vaccines by Application (2018-2029)
Figure 58. Global Revenue Market Share of Anti-Infective Vaccines by Application (2018-2029)
Figure 59. Global Anti-Infective Vaccines Pric

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Keyhole Limpet Hemocyanin (Klh) Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 118

The Keyhole Limpet Hemocyanin (Klh) market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Keyhole Limpet Hemocyanin (Klh) industry, and breaks down according to the type, application, and consumption area of Keyhole Limpet Hemocyanin (Klh). The report also introduces players in the industry from the perspective of the industry ch......

Global Recombinant Protein Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 127

The Recombinant Protein market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Recombinant Protein industry, and breaks down according to the type, application, and consumption area of Recombinant Protein. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......

Global Chitosan Gel Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 108

The Chitosan Gel market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Chitosan Gel industry, and breaks down according to the type, application, and consumption area of Chitosan Gel. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading compani......

Global Chlorhexidine Gluconate (CHG) Solution Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 124

Chlorhexidine gluconate is a biguanide chlorobenzene with a wide range of antimicrobial activity. It is the most Gram-positive (10mcg/ml) and Gram-negative (50mcg/ml) bacteria at pH 5.0-8.0. effective The Chlorhexidine Gluconate (CHG) Solution market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Chlorhexidine Gluconate (C......

Global Hemostat Powder Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 110

Hemostat powder , such as QuikClot and Celox, rapidly stop bleeding by either promoting coagulation or contracting tissue. Hemostatics can be critical to saving someone's life making them an excellent part of a first aid kit. The Hemostat Powder market revenue was 361.37 Million USD in 2022, and will reach 578.21 Million USD in 2028, with a CAGR of 8.15% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Hemostat Powde......

Global Herbal Medicine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 116

The Herbal Medicine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Herbal Medicine industry, and breaks down according to the type, application, and consumption area of Herbal Medicine. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leadin......

Global Medicinal Mushroom Extracts Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 122

The Medicinal Mushroom Extracts market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Medicinal Mushroom Extracts industry, and breaks down according to the type, application, and consumption area of Medicinal Mushroom Extracts. The report also introduces players in the industry from the perspective of the industry chain and mark......

Global Animal Antibacterial And Antibiotics Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 110

Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms, not only among pathogens but also among bacteria of the endogenous microflora of animals. The extent to which antibiotic use in animals will contribute to the antibiotic resistance in humans is still under much debate. The Animal Antibacterial And Antibiotics market rev......

Global Analytical Standards Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108

The Analytical Standards market revenue was 2055.18 Million USD in 2022, and will reach 3275.31 Million USD in 2028, with a CAGR of 8.08% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Analytical Standards industry, and breaks down according to the type, application, and consumption area of Analytical Standards. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs